These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15887515)

  • 1. [Economic evaluation as a component in the evaluation of a prevention program].
    Rydlewska-Liszkowska I
    Med Pr; 2004; 55(6):469-75. PubMed ID: 15887515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
    Krauth C; John J; Aidelsburger P; Brüggenjürgen B; Hansmeier T; Hessel F; Kohlmann T; Moock J; Rothgang H; Schweikert B; Seitz R; Wasem J;
    Gesundheitswesen; 2008 Jun; 70(6):e1-16. PubMed ID: 18661452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health services and health economics].
    Cilingiroglu N
    Nufusbil Derg; 1988; 10():45-50. PubMed ID: 12342133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
    Abramowitz S; Greene D
    AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing prevention effectiveness using data to drive program decisions.
    Thacker SB; Koplan JP; Taylor WR; Hinman AR; Katz MF; Roper WL
    Public Health Rep; 1994; 109(2):187-94. PubMed ID: 8153269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic analysis of prevention: an illustration involving children's behavior problems.
    Foster EM; Jones DE
    J Ment Health Policy Econ; 2007 Dec; 10(4):165-75. PubMed ID: 18166828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost effectiveness of occupational health interventions: preventing occupational back pain.
    Lahiri S; Markkanen P; Levenstein C
    Am J Ind Med; 2005 Dec; 48(6):515-29. PubMed ID: 16299706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Models of economic evaluation of health and safety interventions at workplace].
    Rydlewska-Liszkowska I
    Med Pr; 2005; 56(5):411-8. PubMed ID: 16483013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children.
    Kyle JW; Hammitt JK; Lim HW; Geller AC; Hall-Jordan LH; Maibach EW; De Fabo EC; Wagner MC
    Pediatrics; 2008 May; 121(5):e1074-84. PubMed ID: 18450850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of transparency of cost estimates in economic evaluations of patient safety programmes.
    Fukuda H; Imanaka Y
    J Eval Clin Pract; 2009 Jun; 15(3):451-9. PubMed ID: 19366392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent developments in the economic evaluation of health].
    Rovira J
    Med Clin (Barc); 2000; 114 Suppl 3():8-14. PubMed ID: 10994558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global strategy for further reducing the leprosy burden and sustaining leprosy control activities 2006-2010. Operational guidelines.
    World Health Organization Regional Office for South-East Asia New Delhi
    Lepr Rev; 2006 Sep; 77(3):IX, X, 1-50. PubMed ID: 17172004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of economic evaluation in local health care decision-making in England: a qualitative investigation.
    Eddama O; Coast J
    Health Policy; 2009 Mar; 89(3):261-70. PubMed ID: 18657336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing and testing a cost-assessment tool for cancer screening programs.
    Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
    Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of tandem mass spectrometry screening in California.
    Feuchtbaum L; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S280-6. PubMed ID: 16735254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health policy decisions on medical innovations: what role can early economic evaluation play?
    Hartz S; John J
    Health Policy; 2009 Feb; 89(2):184-92. PubMed ID: 18619704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.